E Genth

Summary

Country: Germany

Publications

  1. ncbi [Patient education in rheumatologic care--a review]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 67:199-205. 2008
  2. ncbi [Patient education: cui bono?]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 67:187-8. 2008
  3. ncbi [Systemic sclerosis - diagnosis and classification]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:268-74. 2006
  4. ncbi [Laboratory diagnosis of rheumatic disease - quo vadis? An integral component of rheumatology]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:195-6. 2007
  5. ncbi [Laboratory diagnostics for systemic sclerosis]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:206, 208-11. 2007
  6. ncbi [Scleroderma associated autoantibodies - clinical and diagnostic relevance]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:279-84. 2006
  7. ncbi [Prof. Dr. Leo B. A. van de Putte]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 64:203-6. 2005
  8. ncbi [Patient education "systemic sclerosis"]
    E Genth
    Leitender Arzt der Rheumaklinik und des Rheumaforschungsinstituts Aachen, Burtscheider Markt 24, 52066 Aachen, Germany
    Z Rheumatol 62:II24-5. 2003
  9. ncbi [Evidence-based therapy of systemic sclerosis]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Burtscheider Markt 24, 52066 Aachen, Germany
    Z Rheumatol 60:464-8. 2001
  10. ncbi Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis
    T Dick
    Rheumaklinik u Rheumaforschungsinstitut, Aachen, Germany
    Ann Rheum Dis 61:121-7. 2002

Collaborators

Detail Information

Publications20

  1. ncbi [Patient education in rheumatologic care--a review]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 67:199-205. 2008
    ..A better understanding of information needs and baseline characteristics of patients is necessary to develop more appropriate educational interventions focussed on relevant outcomes that can be improved by educational measures...
  2. ncbi [Patient education: cui bono?]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 67:187-8. 2008
  3. ncbi [Systemic sclerosis - diagnosis and classification]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:268-74. 2006
    ....
  4. ncbi [Laboratory diagnosis of rheumatic disease - quo vadis? An integral component of rheumatology]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:195-6. 2007
  5. ncbi [Laboratory diagnostics for systemic sclerosis]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:206, 208-11. 2007
    ..Numerous additional laboratory parameters are of value for investigating pathogenesis, but have not yet been generally introduced into the routine diagnostics of systemic sclerosis...
  6. ncbi [Scleroderma associated autoantibodies - clinical and diagnostic relevance]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:279-84. 2006
    ..Some, however, are thought to be relevant to the as yet unanswered question of whether autoantibodies are directly involved in SSc pathogenesis...
  7. ncbi [Prof. Dr. Leo B. A. van de Putte]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 64:203-6. 2005
  8. ncbi [Patient education "systemic sclerosis"]
    E Genth
    Leitender Arzt der Rheumaklinik und des Rheumaforschungsinstituts Aachen, Burtscheider Markt 24, 52066 Aachen, Germany
    Z Rheumatol 62:II24-5. 2003
    ..The program consisting of 7 modules is now in the final test phase...
  9. ncbi [Evidence-based therapy of systemic sclerosis]
    E Genth
    Rheumaklinik und Rheumaforschungsinstitut Burtscheider Markt 24, 52066 Aachen, Germany
    Z Rheumatol 60:464-8. 2001
    ..Physical therapies (e.g., massage) are poorly studied. In particular cases, surgical measures (e.g., removal of calcifications) are necessary...
  10. ncbi Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis
    T Dick
    Rheumaklinik u Rheumaforschungsinstitut, Aachen, Germany
    Ann Rheum Dis 61:121-7. 2002
    ..Antibodies targeting DNA topoisomerase I (ATA) or centromere proteins (ACA) are associated with clinical subsets of patients with systemic sclerosis (SSc). The occurrence of those autoantibodies is considered to be mutually exclusive...
  11. ncbi [Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)]
    N Hunzelmann
    Klinik und Poliklinik fur Dermatologie und Venerologie, Klinikum der Universität zu Köln, 50924 Köln, Deutschland
    Z Rheumatol 67:334-6, 337-40. 2008
    ....
  12. ncbi [Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany]
    W Mau
    Institut für Rehabilitationsmedizin, Medizinische Fakultät der Martin Luther Universität Halle Wittenberg, 06097, Halle Saale, Deutschland
    Z Rheumatol 67:157-64. 2008
    ..They may be useful for the advice and care of individual patients as well as for decision processes concerning the health care system...
  13. ncbi [Fibromyalgia]
    W H Jäckel
    Rheumaklinik Bad Säckingen, Bergseestrasse 61, 79713, Bad Sackingen, Deutschland
    Z Rheumatol 66:579-90. 2007
    ..In addition to early diagnosis and intensive patient education, pharmacotherapy, exercise therapy, behavior therapy, and multidisciplinary treatment are particularly important for the management of fibromyalgia...
  14. ncbi [80 years of the German society for rheumatology]
    A Radbruch
    Z Rheumatol 66:551-3. 2007
  15. ncbi [Academy for Graduate and Continuing Education in Rheumatology]
    W L Gross
    Z Rheumatol 63:472. 2004
  16. ncbi [Imaging techniques in rheumatology]
    E Genth
    Z Rheumatol 62:21-2. 2003
  17. ncbi [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis]
    S Kim
    , Joseph-Stelzmann-Strasse 9, , Germany
    Z Rheumatol 64:499-502. 2005
    ..Our case underlines that in patients with anti-PM-Scl-positive systemic sclerosis and treatment resistant progressive myopathy the diagnosis of inclusion body myositis should be considered...
  18. ncbi The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation
    H P Seelig
    Institute of Immunology and Molecular Genetics, Karlsruhe, Germany
    Arthritis Rheum 38:1389-99. 1995
    ..To characterize the complementary DNA (cDNA) and protein sequences of autoantigens recognized by anti-Mi-2 antibodies, using recombinant Mi-2 proteins for improved autoantibody detection...